ArticleHealth science reports2025
A Review on the Double Burden of Diabetes and Myocardial Infarction: Healthcare Challenges and Future Prospects in Low and Middle-Income Countries.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prevalence of diabetic cardiomyopathy in low- and middle-income countries: a systematic review protocol.Systematic reviews · 2026Article
- A FRET Aptasensor Based on N-CQDs for Detection of Cardiac Troponin I in Acute Myocardial Infarction Diagnosis.International journal of nanomedicine · 2026Article
- Prognostic significance of pan-immune-inflammatory value in adverse cardiovascular and cerebrovascular events post-percutaneous coronary intervention in diabetic patients with coronary heart disease.Frontiers in cardiovascular medicine · 2026Article
- A Review on the Double Burden of Diabetes and Myocardial Infarction: Healthcare Challenges and Future Prospects in Low and Middle-Income Countries.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: The dual burden of diabetes and myocardial infarction (MI) significantly increases morbidity and mortality, especially in low- and middle-income countries (LMICs). This study evaluates current treatment strategies, emphasizing the impact of limited access to medications, diagnostics, and specialized care. It proposes adaptable solutions tailored to resource-constrained settings. Method: For this review study, we investigated many databases-including PubMed, Scopus, Embase, Web of Science, Google Scholar, and the Cochrane Library-using different relevant terms. Discussion: Low public awareness and healthcare limitations often delay diagnosis and treatment, leading to poor outcomes. While comprehensive care, including medication, lifestyle modification, and education, is ideal, it remains out of reach for many LMICs due to systemic barriers. Conclusion: Improving chronic disease outcomes in LMICs requires targeted investment in healthcare infrastructure, patient education, and scalable interventions. Community-based care, digital tools, and task-shifting models show strong potential for enhancing disease management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.